In preclinical models, it displayed potent anti-tumour efficacy in TGF-β2-overexpressing PDAC cells, and drastically inhibited cell invasion, and also inhibited tumour growth, angiogenesis and lymph node metastasis in an orthotopic xenograft mouse model of metastatic PDAC[97]. This evidence concerns the gene TGFB2 and neoplasm.